Leuprolide
Performance & EnduranceGnRH agonist for testosterone suppression in prostate cancer, endometriosis, and other conditions.
Key Benefits
- ✓Testosterone suppression for medical conditions
- ✓Treats endometriosis
- ✓Manages uterine fibroids
- ✓Prostate cancer treatment
- ✓Precocious puberty management
Dosing Information
Detailed Protocol
Administered via subcutaneous or intramuscular injection as depot formulation. Available in 1-month, 3-month, 4-month, and 6-month formulations. Medical prescription required.
About Leuprolide
Leuprolide is a synthetic nonapeptide analog of GnRH. With continuous administration, it suppresses gonadotropin secretion and testosterone/estrogen production. FDA-approved for multiple indications including prostate cancer, endometriosis, and uterine fibroids.
Research Notes
FDA-approved for multiple indications. Extensive clinical use since 1985. Well-established efficacy for hormone-responsive conditions.
Potential Side Effects
- •Hot flashes
- •Decreased libido
- •Mood changes
- •Bone density reduction
- •Injection site reactions
- •Medical supervision required
Always consult with a healthcare professional before starting any peptide therapy.